Chuck Miller

SVP of Regulatory Affairs

Chuck joined Mersana in August 2020 with over 25 years of regulatory affairs, program leadership, and product development experience. Prior to Mersana, he served as Vice President of Regulatory Strategy and Labeling at TESARO, Inc before its acquisition by GSK. While at TESARO he was part of the research and development leadership team that provided strategic direction and management of development teams across the entire portfolio. He was instrumental in the approval of ZEJULA® (niraparib) in multiple indications and geographies. Previously, he worked as Executive Director of Regulatory Affairs at Cubist, before its acquisition by Merck. He has also worked in regulatory strategy and affairs at Vertex Pharmaceuticals, Idenix Pharmaceuticals and Acambis Inc.

Chuck holds a B.A. in Biochemistry and Molecular Biology from Boston University.

Roles at Mersana Therapeutics

  • SVP of Regulatory Affairs

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Mersana Therapeutics

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams